RT Journal Article
SR Electronic
T1 Estimating the epidemic growth dynamics within the first week
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.08.14.20170878
DO 10.1101/2020.08.14.20170878
A1 Fioriti, Enzo
A1 Chinnici, Marta
A1 Arbore, Andrea
A1 Sigismondi, Nicola
A1 Roselli, Ivan
YR 2020
UL http://medrxiv.org/content/early/2020/08/15/2020.08.14.20170878.abstract
AB Information about the early growth of infectious outbreaks are indispensable to estimate the epidemic spreading. A large number of mathematical tools have been developed to this end, facing as much large number of different dynamic evolutions, ranging from sub-linear to super-exponential growth. Of course, the crucial point is that we do not have enough data during the initial outbreak phase to make reliable inferences. Here we propose a methodology to estimate the epidemic growth dynamics from the infected cumulative data of just a week, provided a surveillance system is available over the whole territory. The methodology, based on the Newcomb-Benford Law, is applied to Italian covid 19 case-study. Results show that it is possible to discriminate the epidemic dynamics using the first seven data points collected over fifty Italian cities. Moreover, the form of the most probable approximating function of the growth, within a six weeks epidemic scenario, is identified.Competing Interest StatementThe authors have declared no competing interest.Clinical Trialno clinical trial necessary. only numerical public data have been processedFunding StatementNO fundingAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:no details neededAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.Yesall data can be freely doenloaded from the link: https://statistichecoronavirus.it/coronavirus-europa/ https://statistichecoronavirus.it/coronavirus-europa/